Published in Lab Law Weekly, March 27th, 2009
For the 2008 fiscal year, the Company reported a net loss of $65.5 million, or $1.71 per share, compared to net income of $53.1 million, or $1.24 per diluted share, for the 2007 fiscal year. This year’s results include a non-cash goodwill impairment charge of $95.4 million, or $2.49 per share. Excluding the impairment charge, the Company’s net income for the fiscal year was $29.8 million, or $0.77 per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly